- Comparison of Efficacy of Peginterferon and Ribavirin Combination Therapy for Chronic Hepatitis C among Korean, Caucasian and Other Asians
-
Kim KA
- KMID: 1775791
- Korean J Gastroenterol.
- 2012 Nov;60(5):273-274.
- doi: 10.4166/kjg.2012.60.5.273
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?
-
Jung YK, Kim JH
- KMID: 1493571
- Clin Mol Hepatol.
- 2013 Mar;19(1):26-28.
- doi: 10.3350/cmh.2013.19.1.26
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of ribavirin dose reduction during treatment in chronic hepatitis C genotype 1 patients
-
Chung WJ
- KMID: 1392905
- Clin Mol Hepatol.
- 2012 Sep;18(3):268-271.
- doi: 10.3350/cmh.2012.18.3.268
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Durability of antiviral therapy for chronic hepatitis C after achieving sustained virological response
-
Heo J
- KMID: 1025196
- Korean J Hepatol.
- 2011 Sep;17(3):180-182.
- doi: 10.3350/kjhep.2011.17.3.180
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The effect of alanine aminotransferase dynamics on predicting sustained virological response in chronic hepatitis C virus infection
-
Kim TY
- KMID: 1372648
- Korean J Hepatol.
- 2012 Mar;18(1):29-31.
- doi: 10.3350/kjhep.2012.18.1.29
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cirrhosis after interferon and ribavirin combination therapy
-
Lee SJ, Cho YK, Na SY, Choi EK, Boo SJ, Jeong SU, Song HJ, Kim HU, Kim BS, Song BC
- KMID: 2373140
- Clin Mol Hepatol.
- 2016 Sep;22(3):390-395.
- doi: 10.3350/cmh.2015.0050
Some recent studies have found regression of liver cirrhosis after antiviral therapy in patients with hepatitis C virus (HCV)-related liver cirrhosis, but there have been no reports of complete regression... -
- CITED
-
- Close
- SHARE
-
- Close
- Potential Efficacy of Pegylated Interferon-α and a Nucleos(t)ide Analogue as Combination Therapy for HBeAg-Positive Chronic Hepatitis B
-
Wi CI, Kim WR, Gross JB, Stadheim L, Poterucha
- KMID: 2412051
- Gut Liver.
- 2016 Jul;10(4):611-616.
- doi: 10.5009/gnl14256
BACKGROUND/AIMS: Despite the potent suppression of the hepatitis B virus with modern antiviral agents, only a minority of HBeAg-positive patients achieve hepatitis B e antigen seroconversion. We aimed to explore... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Peginterferon and Ribavirin Combination Therapy of Chronic Hepatitis C: A Pooled Analysis
-
Park SY, Rim MY, Yo IK, Ha MS, Kim JS, Lee JW, Jung YK, Kwon OS, Kim YS, Choi DJ, Kim JH
- KMID: 1775796
- Korean J Gastroenterol.
- 2012 Nov;60(5):306-314.
- doi: 10.4166/kjg.2012.60.5.306
BACKGROUND/AIMS: A combination of peginterferon and ribavirin is the standard therapy for chronic hepatitis C (CHC). However, the respective study has not been carried out in a large scale in... -
- CITED
-
- Close
- SHARE
-
- Close
- The Impact of Inosine Triphosphatase Variants on Hemoglobin Level and Sustained Virologic Response of Chronic Hepatitis C in Korean
-
Kim JS, Ahn SM, Jung YK, Kwon OS, Kim YS, Choi DJ, Kim JH
- KMID: 1793028
- J Korean Med Sci.
- 2013 Aug;28(8):1213-1219.
- doi: 10.3346/jkms.2013.28.8.1213
Two variants of the inosine triphosphatase (ITPA: rs1127354, rs7270101) gene cause ITPA deficiency and protect against the hemolytic toxicity of ribavirin. We investigated the clinical significance of ITPA variants in... -
- CITED
-
- Close
- SHARE
-
- Close
- Association of IL28B Genotypes and Baseline Serum Interferon-γ-Inducible-Protein-10 Levels with Treatment Response in Hepatitis C Virus Patients in China
-
Zhang R, Shao C, Huo N, Li M, Xu X
- KMID: 2411973
- Gut Liver.
- 2016 May;10(3):446-455.
- doi: 10.5009/gnl15162
BACKGROUND/AIMS: Several studies have demonstrated that serum interferon-γ-inducible-protein-10 (IP-10) levels at baseline and single nucleotide polymorphisms (SNPs) near the IL28B gene were associated with viral response and treatment outcomes. Our... -
- CITED
-
- Close
- SHARE
-
- Close
- Advanced fibrosis is not a negative pretreatment predictive factor for genotype 2 or 3 chronic hepatitis C patients
-
Lee HS, Kweon YO, Tak WY, Park SY, Kang EJ, Lee YL, Yang HM, Park HW
- KMID: 1776802
- Clin Mol Hepatol.
- 2013 Jun;19(2):148-155.
- doi: 10.3350/cmh.2013.19.2.148
BACKGROUND/AIMS: Chronic hepatitis C patients with advanced fibrosis have unsatisfactory sustained virological response (SVR) rates. Few data demonstrating the efficacy of combination therapy in chronic hepatitis C patients with advanced... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Utility of a New Automated Hepatitis C Virus Core Antigen Assay for Prediction of Treatment Response in Patients with Chronic Hepatitis C
-
Kim MN, Kim HS, Kim JK, Kim BK, Kim SU, Park JY, Kim DY, Ahn SH, Han KH
- KMID: 2468276
- J Korean Med Sci.
- 2016 Sep;31(9):1431-1437.
- doi: 10.3346/jkms.2016.31.9.1431
Hepatitis C virus core antigen (HCV Ag) is a recently developed marker of hepatitis C virus (HCV) infection. We investigated the clinical utility of the new HCV Ag assay for... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence, Risk Factors and Clinical Characteristics in Patients with Genotype 6 Chronic Hepatitis C: A Single Institute Experience
-
Shin SK, Park SY, Jung YK, Kim EJ, Lee HN, Lee JJ, Kwon OS, Choi DJ, Kim YS, Kim JH
- KMID: 2373191
- Korean J Gastroenterol.
- 2015 Feb;65(2):105-111.
- doi: 10.4166/kjg.2015.65.2.105
BACKGROUND/AIMS: Hepatitis C genotypes 1 and 2 are widely distributed globally. In contrast, genotype 6 is found mainly in Southeast Asia, while genotype 6 is rare in Korea. This study... -
- CITED
-
- Close
- SHARE
-
- Close
- Secreted Phosphoprotein 1 Promoter Genetic Variants Are Associated with the Response to Pegylated Interferon alpha Plus Ribavirin Combination Therapy in Egyptian Patients with Chronic Hepatitis C Virus Infection
-
Ali FT, Ali MA, Elgizawy M, Elsawy AM
- KMID: 2160636
- Gut Liver.
- 2015 Jul;9(4):516-524.
- doi: 10.5009/gnl14162
BACKGROUND/AIMS: The T-helper 1 (TH1) immune reaction is essential for the eradication of hepatitis C virus (HCV) during pegylated interferon alpha (PEG-IFN-alpha)- and ribavirin (RBV)-based therapy in chronic HCV patients.... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behcet's Disease
-
Park JY, Chung YR, Lee K, Song JH, Lee ES
- KMID: 2366362
- Yonsei Med J.
- 2015 Jul;56(4):1158-1162.
- doi: 10.3349/ymj.2015.56.4.1158
Behcet's disease (BD) involves multisystem vasculitis of unknown origin. Ocular manifestations of BD mostly include bilateral panuveitis and retinal vasculitis, which are very challenging to treat. Interferon alfa-2a (IFN) has... -
- CITED
-
- Close
- SHARE
-
- Close
- Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response
-
Lee HW, Chon YE, Kim SU, Kim BK, Park JY, Kim DY, Ahn SH, Jung KS, Park YN, Han KH
- KMID: 2411971
- Gut Liver.
- 2016 May;10(3):429-436.
- doi: 10.5009/gnl15021
BACKGROUND/AIMS: Few studies have investigated prognostic factors for the development of liver-related events (LREs) in patients with chronic hepatitis C (CHC) who achieve sustained virological response (SVR). METHODS: We analyzed 190... -
- CITED
-
- Close
- SHARE
-
- Close
- Erythropoietin Improves Long-Term Outcomes in Patients with Acute Kidney Injury after Coronary Artery Bypass Grafting
-
Oh SW, Chin HJ, Chae DW, Na KY
- KMID: 1372792
- J Korean Med Sci.
- 2012 May;27(5):506-511.
- doi: 10.3346/jkms.2012.27.5.506
Previous studies reported the beneficial effect of erythropoietin (EPO) in acute injuries. We followed patients with and without acute kidney injury (AKI) after coronary artery bypass grafting (CABG) and evaluated... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of Recombinant Factor VIIa Treatment for Massive Hemorrhage in Patients with Multiple Traumas
-
Koh YR, Cho SJ, Yeom SR, Chang CL, Lee EY, Son HC, Kim HH
- KMID: 1245255
- Ann Lab Med.
- 2012 Mar;32(2):145-152.
- doi: 10.3343/alm.2012.32.2.145
BACKGROUND: Recent studies and case reports have shown that recombinant factor VIIa (rFVIIa) treatment is effective for reversing coagulopathy and reducing blood transfusion requirements in trauma patients with life-threatening hemorrhage.... -
- CITED
-
- Close
- SHARE
-
- Close
- Combined Administration of Glutamine and Growth Hormone Synergistically Reduces Bacterial Translocation in Sepsis
-
Jung SE, Youn YK, Lim YS, Song HG, Rhee JE, Suh GJ
- KMID: 1099787
- J Korean Med Sci.
- 2003 Feb;18(1):17-22.
- doi: 10.3346/jkms.2003.18.1.17
We investigated the combined effect of glutamine (GLN) and growth hormone (GH) on bacterial translocation (BT) in sepsis. After single intraperitoneal injection of lipopolysaccharide (10 mg/kg), 48 rats were divided... -
- CITED
-
- Close
- SHARE
-
- Close
- No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients
-
Heo NY, Lim YS, Lee W, Oh M, An J, Lee D, Shim JH, Kim KM, Lee HC, Lee YS, Suh DJ
- KMID: 1788567
- Clin Mol Hepatol.
- 2014 Jun;20(2):177-184.
- doi: 10.3350/cmh.2014.20.2.177
BACKGROUND/AIMS: There are few available data regarding the association between the single nucleotide polymorphisms (SNPs) of the gene encoding interleukin 28B (IL28B) and a sustained virologic response (SVR) to peginterferon... -
- CITED
-
- Close
- SHARE
-
- Close
